Primary Peritoneal Carcinoma Terminated Phase 2 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01685255A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyTreatment